1. Home
  2. COSM vs COHN Comparison

COSM vs COHN Comparison

Compare COSM & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COSM
  • COHN
  • Stock Information
  • Founded
  • COSM 2009
  • COHN 1999
  • Country
  • COSM United States
  • COHN United States
  • Employees
  • COSM 123
  • COHN N/A
  • Industry
  • COSM Other Pharmaceuticals
  • COHN Investment Bankers/Brokers/Service
  • Sector
  • COSM Health Care
  • COHN Finance
  • Exchange
  • COSM Nasdaq
  • COHN Nasdaq
  • Market Cap
  • COSM 10.1M
  • COHN 17.8M
  • IPO Year
  • COSM 2013
  • COHN N/A
  • Fundamental
  • Price
  • COSM $0.43
  • COHN $8.30
  • Analyst Decision
  • COSM
  • COHN
  • Analyst Count
  • COSM 0
  • COHN 0
  • Target Price
  • COSM N/A
  • COHN N/A
  • AVG Volume (30 Days)
  • COSM 124.6K
  • COHN 8.5K
  • Earning Date
  • COSM 11-14-2024
  • COHN 03-10-2025
  • Dividend Yield
  • COSM N/A
  • COHN 12.06%
  • EPS Growth
  • COSM N/A
  • COHN N/A
  • EPS
  • COSM N/A
  • COHN N/A
  • Revenue
  • COSM $56,042,109.00
  • COHN $73,777,000.00
  • Revenue This Year
  • COSM $4.53
  • COHN N/A
  • Revenue Next Year
  • COSM $25.00
  • COHN N/A
  • P/E Ratio
  • COSM N/A
  • COHN N/A
  • Revenue Growth
  • COSM 13.02
  • COHN N/A
  • 52 Week Low
  • COSM $0.35
  • COHN $6.10
  • 52 Week High
  • COSM $1.58
  • COHN $12.82
  • Technical
  • Relative Strength Index (RSI)
  • COSM 34.13
  • COHN 39.09
  • Support Level
  • COSM $0.35
  • COHN $8.01
  • Resistance Level
  • COSM $0.52
  • COHN $9.45
  • Average True Range (ATR)
  • COSM 0.04
  • COHN 0.46
  • MACD
  • COSM 0.00
  • COHN 0.02
  • Stochastic Oscillator
  • COSM 49.14
  • COHN 30.77

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

Share on Social Networks: